ASH 2023 | The role of antiphospholipid antibodies in SCD
Santosh Saraf, MD, University of Illinois Hospital, Chicago, IL, discusses the role of antiphospholipid antibodies in sickle cell disease (SCD). These autoimmune antibodies are produced in response to disrupted cell membrane polarity and a pro-inflammatory state, exacerbating vascular damage and contributing to multiple organ failure. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consultancy: Agios, Novartis, BEAM Therapeutics, Forma Therapeutics, GBT/Pfizer
Advisory board: Agios, Novartis, BEAM Therapeutics, Forma Therapeutics, GBT/Pfizer
Research Funding: Novartis, Forma Therapeutics, GBT/Pfizer
Speakers Bureau: GBT/Pfizer
